Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Stents | 77 | 2023 | 877 | 9.240 |
Why?
|
Aortic Aneurysm, Abdominal | 46 | 2024 | 443 | 8.590 |
Why?
|
Transcatheter Aortic Valve Replacement | 19 | 2024 | 197 | 8.580 |
Why?
|
Blood Vessel Prosthesis Implantation | 52 | 2024 | 796 | 8.310 |
Why?
|
Endovascular Procedures | 36 | 2024 | 729 | 8.140 |
Why?
|
Aortic Valve Stenosis | 17 | 2024 | 332 | 7.310 |
Why?
|
Blood Vessel Prosthesis | 38 | 2020 | 533 | 7.200 |
Why?
|
Heart Valve Prosthesis Implantation | 12 | 2022 | 429 | 5.120 |
Why?
|
Heart Valve Prosthesis | 17 | 2022 | 293 | 5.040 |
Why?
|
Treatment Outcome | 109 | 2024 | 12109 | 4.600 |
Why?
|
Percutaneous Coronary Intervention | 8 | 2023 | 233 | 4.420 |
Why?
|
Aortic Valve | 18 | 2024 | 437 | 4.030 |
Why?
|
Angioplasty, Balloon | 19 | 2017 | 161 | 3.390 |
Why?
|
Vascular Closure Devices | 8 | 2024 | 14 | 3.270 |
Why?
|
Prosthesis Design | 32 | 2023 | 672 | 2.530 |
Why?
|
Femoral Artery | 21 | 2021 | 190 | 2.520 |
Why?
|
Coronary Artery Disease | 7 | 2023 | 748 | 2.370 |
Why?
|
Pulmonary Valve | 4 | 2020 | 94 | 2.360 |
Why?
|
Hemostatic Techniques | 8 | 2024 | 32 | 2.330 |
Why?
|
Carotid Stenosis | 11 | 2018 | 133 | 2.270 |
Why?
|
Aortic Aneurysm, Thoracic | 10 | 2024 | 664 | 2.040 |
Why?
|
Catheterization, Peripheral | 7 | 2024 | 126 | 1.950 |
Why?
|
Aorta, Abdominal | 8 | 2018 | 120 | 1.950 |
Why?
|
Angioplasty | 8 | 2018 | 85 | 1.910 |
Why?
|
Mitral Valve Insufficiency | 3 | 2022 | 156 | 1.900 |
Why?
|
Humans | 183 | 2024 | 123046 | 1.860 |
Why?
|
Aortic Aneurysm | 4 | 2020 | 224 | 1.820 |
Why?
|
Patient Discharge | 4 | 2019 | 486 | 1.780 |
Why?
|
Cardiac Catheterization | 15 | 2022 | 631 | 1.730 |
Why?
|
Arterial Occlusive Diseases | 11 | 2016 | 127 | 1.650 |
Why?
|
Aneurysm | 8 | 2018 | 88 | 1.600 |
Why?
|
Mitral Valve | 10 | 2023 | 245 | 1.540 |
Why?
|
Aortography | 20 | 2019 | 200 | 1.510 |
Why?
|
Peripheral Arterial Disease | 5 | 2020 | 271 | 1.470 |
Why?
|
Foramen Ovale, Patent | 2 | 2021 | 15 | 1.400 |
Why?
|
Aortic Diseases | 3 | 2020 | 197 | 1.330 |
Why?
|
Aortic Coarctation | 4 | 2017 | 105 | 1.330 |
Why?
|
Aneurysm, False | 4 | 2018 | 102 | 1.320 |
Why?
|
Time Factors | 31 | 2024 | 6218 | 1.280 |
Why?
|
Suture Techniques | 7 | 2024 | 196 | 1.270 |
Why?
|
Aortic Valve Insufficiency | 2 | 2020 | 140 | 1.250 |
Why?
|
Artificial Intelligence | 2 | 2022 | 239 | 1.240 |
Why?
|
Bioprosthesis | 3 | 2021 | 111 | 1.230 |
Why?
|
Conscious Sedation | 3 | 2021 | 63 | 1.200 |
Why?
|
Popliteal Artery | 6 | 2016 | 53 | 1.200 |
Why?
|
Stroke | 5 | 2021 | 955 | 1.190 |
Why?
|
Aged | 73 | 2024 | 19083 | 1.170 |
Why?
|
Endoleak | 4 | 2019 | 43 | 1.150 |
Why?
|
Thrombectomy | 6 | 2020 | 103 | 1.140 |
Why?
|
Length of Stay | 7 | 2021 | 1288 | 1.140 |
Why?
|
Aorta, Thoracic | 4 | 2020 | 520 | 1.100 |
Why?
|
Punctures | 7 | 2024 | 55 | 1.060 |
Why?
|
Aged, 80 and over | 33 | 2024 | 6371 | 1.050 |
Why?
|
Peripheral Vascular Diseases | 5 | 2011 | 89 | 1.040 |
Why?
|
Hemorrhage | 5 | 2024 | 458 | 1.030 |
Why?
|
Anesthesia, Local | 2 | 2019 | 48 | 1.030 |
Why?
|
Vascular Surgical Procedures | 9 | 2013 | 565 | 0.990 |
Why?
|
Heart Septum | 5 | 2021 | 55 | 0.970 |
Why?
|
Thrombosis | 6 | 2018 | 520 | 0.950 |
Why?
|
Iliac Artery | 7 | 2003 | 92 | 0.880 |
Why?
|
Academies and Institutes | 2 | 2023 | 83 | 0.880 |
Why?
|
Registries | 8 | 2020 | 1394 | 0.870 |
Why?
|
Endarterectomy, Carotid | 5 | 2018 | 92 | 0.860 |
Why?
|
Tomography, X-Ray Computed | 19 | 2016 | 2055 | 0.850 |
Why?
|
Embolization, Therapeutic | 4 | 2017 | 227 | 0.840 |
Why?
|
Machine Learning | 2 | 2022 | 220 | 0.820 |
Why?
|
Vascular Fistula | 2 | 2018 | 30 | 0.810 |
Why?
|
Absorbable Implants | 2 | 2023 | 23 | 0.800 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2022 | 63 | 0.800 |
Why?
|
Triiodobenzoic Acids | 1 | 2022 | 28 | 0.780 |
Why?
|
Education, Medical, Graduate | 2 | 2021 | 507 | 0.780 |
Why?
|
Atherectomy, Coronary | 2 | 2021 | 9 | 0.750 |
Why?
|
Male | 84 | 2024 | 60089 | 0.740 |
Why?
|
Mitral Valve Annuloplasty | 1 | 2021 | 15 | 0.730 |
Why?
|
Risk Factors | 21 | 2024 | 10009 | 0.730 |
Why?
|
Cardiac Surgical Procedures | 3 | 2021 | 1099 | 0.720 |
Why?
|
Prostheses and Implants | 2 | 2020 | 150 | 0.710 |
Why?
|
Prospective Studies | 17 | 2024 | 6027 | 0.710 |
Why?
|
Angioplasty, Balloon, Coronary | 5 | 2017 | 172 | 0.710 |
Why?
|
Heart Valve Diseases | 1 | 2022 | 166 | 0.710 |
Why?
|
Coronary Occlusion | 1 | 2020 | 27 | 0.700 |
Why?
|
Vascular Calcification | 1 | 2021 | 53 | 0.690 |
Why?
|
Minimally Invasive Surgical Procedures | 3 | 2019 | 193 | 0.680 |
Why?
|
Pulmonary Artery | 3 | 2020 | 439 | 0.680 |
Why?
|
Hemostatics | 1 | 2020 | 58 | 0.680 |
Why?
|
Contrast Media | 2 | 2022 | 470 | 0.680 |
Why?
|
Renal Artery | 2 | 2016 | 74 | 0.680 |
Why?
|
Hemostasis | 1 | 2020 | 69 | 0.670 |
Why?
|
Middle Aged | 64 | 2024 | 25972 | 0.670 |
Why?
|
Cryotherapy | 2 | 2011 | 24 | 0.660 |
Why?
|
Postoperative Complications | 14 | 2018 | 3011 | 0.650 |
Why?
|
Vascular System Injuries | 1 | 2020 | 53 | 0.650 |
Why?
|
Stenosis, Pulmonary Artery | 1 | 2019 | 5 | 0.650 |
Why?
|
Transplant Recipients | 1 | 2021 | 209 | 0.640 |
Why?
|
Female | 79 | 2024 | 65482 | 0.640 |
Why?
|
Carotid Artery, Common | 5 | 2007 | 73 | 0.640 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2020 | 94 | 0.630 |
Why?
|
Coronary Restenosis | 2 | 2017 | 20 | 0.630 |
Why?
|
Graft Occlusion, Vascular | 5 | 2020 | 95 | 0.620 |
Why?
|
Septal Occluder Device | 1 | 2019 | 42 | 0.610 |
Why?
|
Leadership | 1 | 2021 | 230 | 0.610 |
Why?
|
Heart | 3 | 2023 | 723 | 0.610 |
Why?
|
Follow-Up Studies | 30 | 2019 | 5038 | 0.610 |
Why?
|
Equipment Design | 11 | 2024 | 604 | 0.610 |
Why?
|
Aortic Rupture | 2 | 2018 | 118 | 0.610 |
Why?
|
Retrospective Studies | 30 | 2021 | 16043 | 0.600 |
Why?
|
Hospital Costs | 1 | 2019 | 177 | 0.600 |
Why?
|
Vascular Patency | 8 | 2020 | 203 | 0.590 |
Why?
|
Periodicals as Topic | 1 | 2021 | 195 | 0.590 |
Why?
|
Heart Septal Defects, Atrial | 2 | 2019 | 121 | 0.590 |
Why?
|
Vena Cava, Inferior | 1 | 2018 | 100 | 0.590 |
Why?
|
Prosthesis Failure | 6 | 2012 | 159 | 0.580 |
Why?
|
Hospitals, Teaching | 1 | 2018 | 105 | 0.580 |
Why?
|
Radiography | 14 | 2016 | 822 | 0.560 |
Why?
|
Lasers | 1 | 2017 | 115 | 0.560 |
Why?
|
Atrial Appendage | 1 | 2017 | 43 | 0.560 |
Why?
|
Drug-Eluting Stents | 1 | 2017 | 54 | 0.560 |
Why?
|
Lung Diseases | 1 | 2020 | 378 | 0.540 |
Why?
|
Aspirin | 1 | 2018 | 224 | 0.540 |
Why?
|
Norwood Procedures | 1 | 2017 | 100 | 0.530 |
Why?
|
Internship and Residency | 2 | 2021 | 1158 | 0.530 |
Why?
|
Women's Health | 1 | 2017 | 132 | 0.530 |
Why?
|
Thoracic Surgical Procedures | 1 | 2017 | 92 | 0.510 |
Why?
|
Equipment Failure | 3 | 2008 | 122 | 0.510 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2016 | 42 | 0.500 |
Why?
|
Cardiology | 1 | 2021 | 473 | 0.500 |
Why?
|
Algorithms | 2 | 2022 | 1596 | 0.500 |
Why?
|
Vascular Malformations | 1 | 2016 | 81 | 0.490 |
Why?
|
Postoperative Hemorrhage | 1 | 2016 | 87 | 0.490 |
Why?
|
Heart-Assist Devices | 2 | 2021 | 1026 | 0.480 |
Why?
|
Lower Extremity | 3 | 2016 | 179 | 0.480 |
Why?
|
Ductus Arteriosus, Patent | 1 | 2017 | 145 | 0.480 |
Why?
|
Feasibility Studies | 6 | 2018 | 755 | 0.480 |
Why?
|
Vascular Access Devices | 2 | 2015 | 35 | 0.470 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2023 | 715 | 0.470 |
Why?
|
Cardiomyopathies | 1 | 2019 | 478 | 0.460 |
Why?
|
Renal Artery Obstruction | 2 | 2008 | 41 | 0.450 |
Why?
|
Texas | 12 | 2011 | 3560 | 0.450 |
Why?
|
Hospitals, High-Volume | 1 | 2014 | 35 | 0.440 |
Why?
|
Platelet Aggregation Inhibitors | 4 | 2020 | 258 | 0.440 |
Why?
|
Risk Assessment | 10 | 2021 | 3313 | 0.430 |
Why?
|
Myocardial Infarction | 3 | 2020 | 1001 | 0.430 |
Why?
|
Renal Dialysis | 1 | 2020 | 842 | 0.420 |
Why?
|
Inpatients | 1 | 2016 | 464 | 0.410 |
Why?
|
Angiography | 10 | 2016 | 215 | 0.410 |
Why?
|
Ultrasonography, Interventional | 2 | 2015 | 196 | 0.400 |
Why?
|
Surgical Wound Infection | 2 | 2006 | 261 | 0.400 |
Why?
|
Research Design | 2 | 2015 | 676 | 0.400 |
Why?
|
United States | 8 | 2021 | 10649 | 0.400 |
Why?
|
Hypertension, Pulmonary | 1 | 2017 | 434 | 0.390 |
Why?
|
Tricuspid Valve | 2 | 2022 | 59 | 0.380 |
Why?
|
Superior Vena Cava Syndrome | 1 | 2011 | 20 | 0.360 |
Why?
|
Intracranial Embolism | 1 | 2010 | 25 | 0.360 |
Why?
|
Reoperation | 7 | 2012 | 818 | 0.360 |
Why?
|
Metals | 2 | 2020 | 61 | 0.350 |
Why?
|
Forecasting | 2 | 2022 | 354 | 0.350 |
Why?
|
Atrial Fibrillation | 1 | 2017 | 626 | 0.350 |
Why?
|
Catheters | 1 | 2010 | 89 | 0.350 |
Why?
|
Iliac Vein | 1 | 2010 | 34 | 0.340 |
Why?
|
Foreign-Body Migration | 1 | 2010 | 74 | 0.330 |
Why?
|
Incidence | 5 | 2022 | 3039 | 0.320 |
Why?
|
Sutures | 2 | 2020 | 67 | 0.320 |
Why?
|
Embolism | 1 | 2009 | 48 | 0.310 |
Why?
|
Recurrence | 9 | 2008 | 1418 | 0.300 |
Why?
|
Urokinase-Type Plasminogen Activator | 2 | 2006 | 41 | 0.300 |
Why?
|
Hemodynamics | 7 | 2020 | 844 | 0.290 |
Why?
|
Carotid Artery Diseases | 2 | 2006 | 147 | 0.280 |
Why?
|
Operative Time | 2 | 2019 | 160 | 0.280 |
Why?
|
Computed Tomography Angiography | 2 | 2019 | 197 | 0.280 |
Why?
|
Heart Arrest | 1 | 2011 | 341 | 0.280 |
Why?
|
Stroke Volume | 6 | 2019 | 445 | 0.270 |
Why?
|
Congresses as Topic | 2 | 2017 | 169 | 0.270 |
Why?
|
Anesthesia, General | 2 | 2018 | 111 | 0.270 |
Why?
|
Thrombolytic Therapy | 3 | 2011 | 204 | 0.260 |
Why?
|
Carotid Artery Injuries | 1 | 2006 | 39 | 0.260 |
Why?
|
Coronary Disease | 8 | 2001 | 637 | 0.260 |
Why?
|
Cardiomyopathy, Hypertrophic | 7 | 1989 | 151 | 0.260 |
Why?
|
Aorta | 3 | 2020 | 542 | 0.260 |
Why?
|
Celiac Artery | 1 | 2006 | 28 | 0.260 |
Why?
|
Arteriovenous Fistula | 1 | 2006 | 56 | 0.250 |
Why?
|
Echocardiography, Transesophageal | 3 | 2017 | 238 | 0.250 |
Why?
|
Cost-Benefit Analysis | 2 | 2019 | 500 | 0.240 |
Why?
|
Program Evaluation | 2 | 2018 | 449 | 0.240 |
Why?
|
Elective Surgical Procedures | 2 | 2016 | 158 | 0.240 |
Why?
|
Carotid-Cavernous Sinus Fistula | 1 | 2004 | 9 | 0.230 |
Why?
|
Polytetrafluoroethylene | 4 | 2010 | 80 | 0.230 |
Why?
|
Fibrinolytic Agents | 1 | 2006 | 198 | 0.230 |
Why?
|
Catheters, Indwelling | 2 | 2002 | 155 | 0.210 |
Why?
|
Coronary Angiography | 7 | 2020 | 420 | 0.210 |
Why?
|
Intestinal Fistula | 1 | 2002 | 28 | 0.210 |
Why?
|
North America | 2 | 2020 | 239 | 0.200 |
Why?
|
Iohexol | 1 | 2022 | 20 | 0.200 |
Why?
|
Adult | 32 | 2019 | 28972 | 0.200 |
Why?
|
Heart Ventricles | 6 | 2021 | 762 | 0.200 |
Why?
|
Credentialing | 1 | 2022 | 18 | 0.200 |
Why?
|
Severity of Illness Index | 5 | 2016 | 2845 | 0.190 |
Why?
|
Staphylococcal Infections | 1 | 2006 | 552 | 0.190 |
Why?
|
Survival Rate | 3 | 2018 | 1999 | 0.190 |
Why?
|
Sirolimus | 1 | 2023 | 220 | 0.190 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2016 | 61 | 0.180 |
Why?
|
Constriction, Pathologic | 3 | 2010 | 240 | 0.180 |
Why?
|
Patient Selection | 2 | 2017 | 683 | 0.180 |
Why?
|
Comorbidity | 5 | 2015 | 1496 | 0.180 |
Why?
|
Echocardiography | 7 | 2016 | 1049 | 0.180 |
Why?
|
Latin America | 1 | 2020 | 88 | 0.180 |
Why?
|
Phlebography | 2 | 2011 | 51 | 0.180 |
Why?
|
Radial Artery | 1 | 2020 | 26 | 0.180 |
Why?
|
Prosthesis-Related Infections | 1 | 2002 | 176 | 0.180 |
Why?
|
Dissent and Disputes | 1 | 2020 | 31 | 0.180 |
Why?
|
Carotid Arteries | 1 | 2001 | 151 | 0.170 |
Why?
|
Myocardial Reperfusion | 1 | 2020 | 73 | 0.170 |
Why?
|
Arteriovenous Malformations | 1 | 2000 | 46 | 0.170 |
Why?
|
Arm | 1 | 2000 | 75 | 0.170 |
Why?
|
Hope | 1 | 2020 | 13 | 0.170 |
Why?
|
Skull | 1 | 2001 | 141 | 0.170 |
Why?
|
Suction | 2 | 2010 | 58 | 0.170 |
Why?
|
Japan | 1 | 2020 | 132 | 0.170 |
Why?
|
Fibromuscular Dysplasia | 1 | 1999 | 7 | 0.170 |
Why?
|
Chi-Square Distribution | 2 | 2011 | 586 | 0.170 |
Why?
|
Retreatment | 1 | 2019 | 88 | 0.160 |
Why?
|
Patient Readmission | 2 | 2020 | 368 | 0.160 |
Why?
|
Cost Savings | 1 | 2019 | 69 | 0.160 |
Why?
|
Solutions | 1 | 2019 | 65 | 0.160 |
Why?
|
Off-Label Use | 1 | 2019 | 25 | 0.160 |
Why?
|
Pilot Projects | 3 | 2010 | 1389 | 0.160 |
Why?
|
Pennsylvania | 1 | 2018 | 50 | 0.160 |
Why?
|
Ventricular Remodeling | 1 | 2019 | 174 | 0.160 |
Why?
|
Coronary Vessels | 2 | 2022 | 526 | 0.160 |
Why?
|
Radiation Injuries | 1 | 2000 | 141 | 0.150 |
Why?
|
Ticlopidine | 1 | 2018 | 28 | 0.150 |
Why?
|
Ultrasonography, Doppler, Duplex | 4 | 2007 | 50 | 0.150 |
Why?
|
Arteriosclerosis | 4 | 2005 | 137 | 0.150 |
Why?
|
Dimethyl Sulfoxide | 1 | 2017 | 18 | 0.150 |
Why?
|
Polyvinyls | 1 | 2017 | 13 | 0.150 |
Why?
|
Dreams | 1 | 2017 | 20 | 0.150 |
Why?
|
Cardiologists | 1 | 2017 | 19 | 0.150 |
Why?
|
Device Removal | 4 | 2002 | 222 | 0.140 |
Why?
|
Everolimus | 1 | 2017 | 46 | 0.140 |
Why?
|
Fibrosis | 1 | 2019 | 429 | 0.140 |
Why?
|
Familial Primary Pulmonary Hypertension | 1 | 2017 | 19 | 0.140 |
Why?
|
Kaplan-Meier Estimate | 2 | 2011 | 1004 | 0.140 |
Why?
|
Creatinine | 1 | 2019 | 380 | 0.140 |
Why?
|
Adenosine | 1 | 2018 | 126 | 0.140 |
Why?
|
Paclitaxel | 1 | 2017 | 120 | 0.140 |
Why?
|
Balloon Valvuloplasty | 1 | 2016 | 25 | 0.140 |
Why?
|
Heterografts | 1 | 2017 | 179 | 0.140 |
Why?
|
Time Management | 1 | 2016 | 11 | 0.130 |
Why?
|
Ductus Arteriosus | 1 | 2017 | 63 | 0.130 |
Why?
|
Efficiency, Organizational | 1 | 2016 | 50 | 0.130 |
Why?
|
Propensity Score | 1 | 2017 | 211 | 0.130 |
Why?
|
Child | 6 | 2020 | 24221 | 0.130 |
Why?
|
Suture Anchors | 1 | 2015 | 3 | 0.130 |
Why?
|
Saphenous Vein | 2 | 2006 | 53 | 0.130 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2015 | 30 | 0.130 |
Why?
|
Paraplegia | 1 | 2016 | 91 | 0.130 |
Why?
|
Pressure | 1 | 2016 | 129 | 0.130 |
Why?
|
Transposition of Great Vessels | 1 | 2017 | 131 | 0.130 |
Why?
|
Ischemia | 2 | 2015 | 343 | 0.130 |
Why?
|
Recovery of Function | 1 | 2017 | 437 | 0.120 |
Why?
|
Cineangiography | 1 | 2015 | 15 | 0.120 |
Why?
|
Brachiocephalic Trunk | 2 | 2005 | 35 | 0.120 |
Why?
|
Combined Modality Therapy | 2 | 2011 | 1236 | 0.120 |
Why?
|
Tomography, Optical Coherence | 1 | 2020 | 516 | 0.120 |
Why?
|
Contraindications | 1 | 2015 | 77 | 0.120 |
Why?
|
Blood Platelets | 1 | 2018 | 333 | 0.120 |
Why?
|
Kidney | 1 | 2022 | 1335 | 0.120 |
Why?
|
Magnetic Resonance Angiography | 2 | 2006 | 169 | 0.120 |
Why?
|
Sex Factors | 1 | 2018 | 1260 | 0.120 |
Why?
|
Coronary Artery Bypass | 5 | 2013 | 489 | 0.120 |
Why?
|
Syndrome | 2 | 2010 | 1115 | 0.110 |
Why?
|
Intensive Care Units | 1 | 2018 | 483 | 0.110 |
Why?
|
Iatrogenic Disease | 2 | 2008 | 132 | 0.110 |
Why?
|
Critical Care | 1 | 2019 | 648 | 0.110 |
Why?
|
Respiratory Insufficiency | 1 | 2016 | 231 | 0.110 |
Why?
|
Swine | 1 | 2017 | 1155 | 0.110 |
Why?
|
Angiography, Digital Subtraction | 3 | 2015 | 51 | 0.110 |
Why?
|
Calcinosis | 1 | 2015 | 170 | 0.110 |
Why?
|
Heart Aneurysm | 2 | 1992 | 38 | 0.110 |
Why?
|
Pain, Postoperative | 1 | 2016 | 256 | 0.110 |
Why?
|
Intermittent Claudication | 2 | 2003 | 55 | 0.100 |
Why?
|
Health Care Costs | 1 | 2015 | 364 | 0.100 |
Why?
|
Polyethylene Terephthalates | 1 | 1992 | 40 | 0.100 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2015 | 577 | 0.100 |
Why?
|
Prevalence | 1 | 2018 | 2395 | 0.100 |
Why?
|
Pericardium | 1 | 1992 | 82 | 0.090 |
Why?
|
Ventricular Function, Left | 2 | 2011 | 496 | 0.090 |
Why?
|
Interinstitutional Relations | 1 | 2011 | 19 | 0.090 |
Why?
|
Ankle Brachial Index | 1 | 2011 | 38 | 0.090 |
Why?
|
Delivery of Health Care | 1 | 2016 | 606 | 0.090 |
Why?
|
Permeability | 1 | 2011 | 118 | 0.090 |
Why?
|
Certification | 1 | 2011 | 67 | 0.090 |
Why?
|
Imaging, Three-Dimensional | 1 | 2013 | 360 | 0.090 |
Why?
|
Multivariate Analysis | 2 | 2011 | 1412 | 0.090 |
Why?
|
Diffusion of Innovation | 1 | 2011 | 97 | 0.090 |
Why?
|
Limb Salvage | 1 | 2011 | 120 | 0.090 |
Why?
|
Ultrasonography | 2 | 2008 | 939 | 0.090 |
Why?
|
Cooperative Behavior | 1 | 2011 | 216 | 0.080 |
Why?
|
Brachiocephalic Veins | 2 | 2005 | 11 | 0.080 |
Why?
|
Case-Control Studies | 2 | 2011 | 3233 | 0.080 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2009 | 109 | 0.080 |
Why?
|
Hypertension, Renovascular | 1 | 2008 | 29 | 0.070 |
Why?
|
Costs and Cost Analysis | 3 | 2019 | 164 | 0.070 |
Why?
|
Odds Ratio | 1 | 2011 | 1242 | 0.070 |
Why?
|
Pulmonary Edema | 1 | 2008 | 49 | 0.070 |
Why?
|
Collateral Circulation | 2 | 2005 | 45 | 0.070 |
Why?
|
Patient Care Team | 1 | 2011 | 548 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2010 | 622 | 0.070 |
Why?
|
Takayasu Arteritis | 2 | 1996 | 13 | 0.070 |
Why?
|
Logistic Models | 1 | 2011 | 1796 | 0.070 |
Why?
|
Anastomosis, Surgical | 1 | 2007 | 169 | 0.070 |
Why?
|
Polyesters | 2 | 2006 | 40 | 0.060 |
Why?
|
Fatal Outcome | 1 | 2006 | 355 | 0.060 |
Why?
|
Wounds, Penetrating | 1 | 2006 | 139 | 0.060 |
Why?
|
Curriculum | 1 | 2011 | 718 | 0.060 |
Why?
|
Transplantation, Autologous | 1 | 2006 | 297 | 0.060 |
Why?
|
Arteries | 1 | 2006 | 221 | 0.060 |
Why?
|
Clinical Competence | 1 | 2011 | 973 | 0.060 |
Why?
|
Vascular Diseases | 1 | 2005 | 163 | 0.050 |
Why?
|
Infant | 1 | 2019 | 12356 | 0.050 |
Why?
|
Cohort Studies | 4 | 2019 | 4699 | 0.050 |
Why?
|
Eikenella corrodens | 1 | 2002 | 4 | 0.050 |
Why?
|
Fusobacterium Infections | 1 | 2002 | 14 | 0.050 |
Why?
|
Blood Circulation | 1 | 2002 | 22 | 0.050 |
Why?
|
Equipment Safety | 1 | 2002 | 37 | 0.050 |
Why?
|
Coronary Vessel Anomalies | 4 | 1980 | 274 | 0.050 |
Why?
|
Staphylococcus aureus | 1 | 2006 | 455 | 0.050 |
Why?
|
Wound Healing | 1 | 2006 | 451 | 0.050 |
Why?
|
Brachial Artery | 2 | 1982 | 38 | 0.050 |
Why?
|
Models, Theoretical | 1 | 2005 | 356 | 0.050 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2002 | 62 | 0.050 |
Why?
|
Internal Mammary-Coronary Artery Anastomosis | 1 | 2001 | 13 | 0.050 |
Why?
|
Subclavian Steal Syndrome | 1 | 2001 | 7 | 0.050 |
Why?
|
Time | 1 | 2001 | 94 | 0.050 |
Why?
|
Perioperative Care | 1 | 2002 | 195 | 0.040 |
Why?
|
Subclavian Artery | 1 | 2001 | 71 | 0.040 |
Why?
|
Anticoagulants | 2 | 2002 | 581 | 0.040 |
Why?
|
Streptococcal Infections | 1 | 2002 | 244 | 0.040 |
Why?
|
Coronary Circulation | 1 | 2001 | 209 | 0.040 |
Why?
|
Diabetes Complications | 1 | 2001 | 196 | 0.040 |
Why?
|
Rupture | 1 | 1999 | 32 | 0.040 |
Why?
|
Blood Vessels | 1 | 2000 | 104 | 0.040 |
Why?
|
Carotid Artery, Internal | 1 | 2000 | 68 | 0.040 |
Why?
|
Nervous System Diseases | 1 | 2002 | 372 | 0.040 |
Why?
|
Cineradiography | 1 | 1998 | 3 | 0.040 |
Why?
|
Plasminogen Activators | 1 | 1998 | 20 | 0.040 |
Why?
|
Fistula | 1 | 1978 | 50 | 0.040 |
Why?
|
Blood Pressure | 1 | 2002 | 1325 | 0.030 |
Why?
|
Survival Analysis | 2 | 2013 | 1473 | 0.030 |
Why?
|
Thoracic Injuries | 1 | 1977 | 91 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2002 | 1008 | 0.030 |
Why?
|
Animals | 1 | 2017 | 33796 | 0.030 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 1977 | 133 | 0.030 |
Why?
|
Leg | 1 | 1997 | 155 | 0.030 |
Why?
|
Wounds, Nonpenetrating | 1 | 1977 | 209 | 0.030 |
Why?
|
Radiography, Interventional | 1 | 2015 | 87 | 0.030 |
Why?
|
Databases, Factual | 1 | 2019 | 1172 | 0.030 |
Why?
|
Echocardiography, Doppler | 2 | 1998 | 170 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2010 | 2110 | 0.030 |
Why?
|
Ventricular Dysfunction, Left | 1 | 1996 | 360 | 0.030 |
Why?
|
Counterpulsation | 1 | 1992 | 4 | 0.030 |
Why?
|
Sex Distribution | 1 | 2013 | 293 | 0.020 |
Why?
|
Adolescent | 7 | 2013 | 19075 | 0.020 |
Why?
|
Age Distribution | 1 | 2013 | 406 | 0.020 |
Why?
|
Intraoperative Care | 1 | 1992 | 103 | 0.020 |
Why?
|
Exercise Test | 2 | 1983 | 249 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2002 | 3544 | 0.020 |
Why?
|
Mitral Valve Stenosis | 2 | 1989 | 34 | 0.020 |
Why?
|
Hospital Mortality | 1 | 1996 | 1010 | 0.020 |
Why?
|
Observer Variation | 1 | 2010 | 295 | 0.020 |
Why?
|
Electrocardiography | 5 | 1987 | 957 | 0.020 |
Why?
|
Myocardial Contraction | 2 | 1989 | 260 | 0.020 |
Why?
|
Cardiac Output | 1 | 1989 | 169 | 0.020 |
Why?
|
Renal Insufficiency | 1 | 2010 | 234 | 0.020 |
Why?
|
Endocarditis, Bacterial | 1 | 1988 | 129 | 0.020 |
Why?
|
Systole | 2 | 2002 | 196 | 0.020 |
Why?
|
Cardiomegaly | 1 | 1987 | 133 | 0.020 |
Why?
|
Laser Therapy | 1 | 1989 | 246 | 0.020 |
Why?
|
Angina Pectoris | 2 | 1985 | 57 | 0.020 |
Why?
|
Life Tables | 1 | 2005 | 29 | 0.020 |
Why?
|
Safety | 1 | 2006 | 218 | 0.020 |
Why?
|
Radionuclide Imaging | 2 | 1983 | 151 | 0.020 |
Why?
|
Alloys | 1 | 2005 | 16 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2006 | 280 | 0.020 |
Why?
|
Elasticity | 1 | 2005 | 92 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2010 | 2826 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2007 | 1305 | 0.010 |
Why?
|
Atropine | 1 | 2002 | 30 | 0.010 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2002 | 22 | 0.010 |
Why?
|
Phenylephrine | 1 | 2002 | 37 | 0.010 |
Why?
|
Ischemic Attack, Transient | 1 | 2002 | 55 | 0.010 |
Why?
|
Bradycardia | 1 | 2002 | 59 | 0.010 |
Why?
|
Decision Support Techniques | 1 | 2005 | 280 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2002 | 249 | 0.010 |
Why?
|
Coated Materials, Biocompatible | 1 | 2002 | 42 | 0.010 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2002 | 219 | 0.010 |
Why?
|
Hypotension | 1 | 2002 | 177 | 0.010 |
Why?
|
Intraoperative Complications | 1 | 1981 | 175 | 0.010 |
Why?
|
Young Adult | 1 | 2013 | 8832 | 0.010 |
Why?
|
Lutembacher Syndrome | 1 | 1978 | 1 | 0.010 |
Why?
|
Ultrasonography, Doppler | 1 | 1999 | 197 | 0.010 |
Why?
|
Warfarin | 1 | 1998 | 118 | 0.010 |
Why?
|
Heart Failure | 1 | 1989 | 2128 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 1998 | 537 | 0.010 |
Why?
|
Mesenteric Artery, Superior | 1 | 1996 | 35 | 0.010 |
Why?
|
Radiography, Thoracic | 1 | 1977 | 152 | 0.010 |
Why?
|
Prognosis | 2 | 2002 | 4512 | 0.010 |
Why?
|
Catheterization | 1 | 1996 | 235 | 0.010 |
Why?
|
Child, Preschool | 1 | 1989 | 13888 | 0.010 |
Why?
|
Pronation | 1 | 1989 | 3 | 0.010 |
Why?
|
Angiocardiography | 1 | 1987 | 13 | 0.000 |
Why?
|
Dilatation, Pathologic | 1 | 1987 | 93 | 0.000 |
Why?
|
Heart Atria | 1 | 1989 | 313 | 0.000 |
Why?
|
Remission, Spontaneous | 1 | 1985 | 68 | 0.000 |
Why?
|
Ambulatory Care | 1 | 1985 | 378 | 0.000 |
Why?
|
Transillumination | 1 | 1981 | 4 | 0.000 |
Why?
|
Heart Diseases | 1 | 1985 | 482 | 0.000 |
Why?
|
Dilatation | 1 | 1981 | 68 | 0.000 |
Why?
|
Risk | 1 | 1981 | 742 | 0.000 |
Why?
|
Sinus of Valsalva | 1 | 1979 | 36 | 0.000 |
Why?
|
Hospitalization | 1 | 1985 | 1728 | 0.000 |
Why?
|